These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34571322)

  • 1. Recent advances in therapeutic nucleic acids and their analytical methods.
    Talap J; Zhao J; Shen M; Song Z; Zhou H; Kang Y; Sun L; Yu L; Zeng S; Cai S
    J Pharm Biomed Anal; 2021 Nov; 206():114368. PubMed ID: 34571322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of therapeutic nucleic acids by capillary electrophoresis.
    Wei B; Goyon A; Zhang K
    J Pharm Biomed Anal; 2022 Sep; 219():114928. PubMed ID: 35853263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights from crystallographic studies into the structural and pairing properties of nucleic acid analogs and chemically modified DNA and RNA oligonucleotides.
    Egli M; Pallan PS
    Annu Rev Biophys Biomol Struct; 2007; 36():281-305. PubMed ID: 17288535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary gel electrophoresis and antisense therapeutics. Analysis of DNA analogs.
    DeDionisio LA; Lloyd DH
    J Chromatogr A; 1996 May; 735(1-2):191-208. PubMed ID: 8767742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases.
    Landmesser U; Poller W; Tsimikas S; Most P; Paneni F; Lüscher TF
    Eur Heart J; 2020 Oct; 41(40):3884-3899. PubMed ID: 32350510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of therapeutic oligonucleotides by liquid chromatography.
    Goyon A; Yehl P; Zhang K
    J Pharm Biomed Anal; 2020 Apr; 182():113105. PubMed ID: 32004766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs.
    Bajan S; Hutvagner G
    Cells; 2020 Jan; 9(1):. PubMed ID: 31936122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative developments and emerging technologies in RNA therapeutics.
    Halloy F; Biscans A; Bujold KE; Debacker A; Hill AC; Lacroix A; Luige O; Strömberg R; Sundstrom L; Vogel J; Ghidini A
    RNA Biol; 2022; 19(1):313-332. PubMed ID: 35188077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics.
    Ingle RG; Fang WJ
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of nucleic acid therapeutics for cancer immunotherapy.
    Zhou S; Chen W; Cole J; Zhu G
    Med Drug Discov; 2020 Jun; 6():. PubMed ID: 34337382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge.
    Colombo S; Zeng X; Ragelle H; Foged C
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1481-95. PubMed ID: 24950005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development.
    Dhuri K; Bechtold C; Quijano E; Pham H; Gupta A; Vikram A; Bahal R
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32604776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes.
    Vetter VC; Wagner E
    J Control Release; 2022 Jun; 346():110-135. PubMed ID: 35436520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA therapeutics: RNAi and antisense mechanisms and clinical applications.
    Chery J
    Postdoc J; 2016 Jul; 4(7):35-50. PubMed ID: 27570789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic Acid Drugs and DNA-based Delivery Systems.
    Nishikawa M
    Drug Discov Ther; 2016 Nov; 10(5):271-272. PubMed ID: 27773889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic Acid Therapeutics in Huntington's Disease.
    Singh K; Roy I
    Recent Pat Biotechnol; 2019; 13(3):187-206. PubMed ID: 30747088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic oligonucleotides: a review].
    Wang X; Xian J; Chen G; Peng H
    Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):664-675. PubMed ID: 29893074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazole- and Tetrazole-Bridged Nucleic Acids: Synthesis, Duplex Stability, Nuclease Resistance, and in Vitro and in Vivo Antisense Potency.
    Mitsuoka Y; Yamamoto T; Kugimiya A; Waki R; Wada F; Tahara S; Sawamura M; Noda M; Fujimura Y; Kato Y; Hari Y; Obika S
    J Org Chem; 2017 Jan; 82(1):12-24. PubMed ID: 27936689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.